Results 2,481-2,500 of 4,350 for speaker:Bobby Aylward

Public Accounts Committee: HSE Financial Statements 2015 and 2016
Clarification of Matters Relating to Meeting of 2 February 2016 (15 Jun 2017)

Bobby Aylward: It is strange.

Public Accounts Committee: HSE Financial Statements 2015 and 2016
Clarification of Matters Relating to Meeting of 2 February 2016 (15 Jun 2017)

Bobby Aylward: I have a few brief questions to follow on from what has been asked. I am talking about the Grace case in particular, what happened in that case and the length of time it took. A witness attended a private meeting of this committee a couple of weeks ago. To listen to that person give the details of what happened to a child left in that situation for 24 years in the area from which I come...

Public Accounts Committee: HSE Financial Statements 2015 and 2016
Clarification of Matters Relating to Meeting of 2 February 2016 (15 Jun 2017)

Bobby Aylward: To be more specific, were the responsible personnel on the ground at the time, and I do not know who they were, ever reprimanded? Was anyone taken to task over the neglect, the wasted time and that this was allowed to happen under their watch? Was anyone ever questioned or forced to pay a cost for it?

Public Accounts Committee: HSE Financial Statements 2015 and 2016
Clarification of Matters Relating to Meeting of 2 February 2016 (15 Jun 2017)

Bobby Aylward: Mr. O'Brien stated previously that all personnel involved were retired and gone and then he or someone else retracted that and said there were still one or two people in the system who had been involved in the Grace case. What is the situation now?

Public Accounts Committee: HSE Financial Statements 2015 and 2016
Clarification of Matters Relating to Meeting of 2 February 2016 (15 Jun 2017)

Bobby Aylward: Should they be?

Public Accounts Committee: HSE Financial Statements 2015 and 2016
Clarification of Matters Relating to Meeting of 2 February 2016 (15 Jun 2017)

Bobby Aylward: Will the Deloitte report, when published, clarify why there was neglect for such a long time in this case and others, as Mr. O'Brien mentioned? Will it make clear to this committee the reasons for this happening, why it was allowed to happen and that it will never happen again?

Public Accounts Committee: HSE Financial Statements 2015 and 2016
Clarification of Matters Relating to Meeting of 2 February 2016 (15 Jun 2017)

Bobby Aylward: Does Mr. O'Brien respect the two whistleblowers who came forward on the HSE? Does he admire and respect what they did and the reason they did it? Does he hold them in high esteem for doing what they did?

Public Accounts Committee: 2015 Annual Report of the Comptroller and Auditor General and Appropriations Account
Chapter 13 - Revenue's Review of Medical Consultants' Tax Affairs
Chapter 14 - Research and Development Tax Credit
Chapter 16 - Deferral of Tobacco Stamp Liability (1 Jun 2017)

Bobby Aylward: They will swap the crown and go as far as the Deputy-----

Public Accounts Committee: 2015 Annual Report of the Comptroller and Auditor General and Appropriations Account
Chapter 13 - Revenue's Review of Medical Consultants' Tax Affairs
Chapter 14 - Research and Development Tax Credit
Chapter 16 - Deferral of Tobacco Stamp Liability (1 Jun 2017)

Bobby Aylward: He does not like giving money back - he likes taking it.

Public Accounts Committee: 2015 Annual Report of the Comptroller and Auditor General and Appropriations Account
Chapter 13 - Revenue's Review of Medical Consultants' Tax Affairs
Chapter 14 - Research and Development Tax Credit
Chapter 16 - Deferral of Tobacco Stamp Liability (1 Jun 2017)

Bobby Aylward: I welcome Revenue. I was going to drop all of my questions and have a chat with Mr. Cody about Saturday week, the Kilkenny line-out and whether he had any insight from having a chat with Brian Cody. He could fill me in.

Public Accounts Committee: 2015 Annual Report of the Comptroller and Auditor General and Appropriations Account
Chapter 13 - Revenue's Review of Medical Consultants' Tax Affairs
Chapter 14 - Research and Development Tax Credit
Chapter 16 - Deferral of Tobacco Stamp Liability (1 Jun 2017)

Bobby Aylward: We might have a chat later.

Public Accounts Committee: 2015 Annual Report of the Comptroller and Auditor General and Appropriations Account
Chapter 13 - Revenue's Review of Medical Consultants' Tax Affairs
Chapter 14 - Research and Development Tax Credit
Chapter 16 - Deferral of Tobacco Stamp Liability (1 Jun 2017)

Bobby Aylward: I started off on it. I threw in the ball first.

Public Accounts Committee: 2015 Annual Report of the Comptroller and Auditor General and Appropriations Account
Chapter 13 - Revenue's Review of Medical Consultants' Tax Affairs
Chapter 14 - Research and Development Tax Credit
Chapter 16 - Deferral of Tobacco Stamp Liability (1 Jun 2017)

Bobby Aylward: That is a non-event. We made sure of that. I will follow on from Deputy Cassells regarding the research and development tax credit and how important it is to small business, particularly in light of Brexit and the many other global challenges that are coming down the line. Brexit will be severe. This credit will play a major role in our future, so I welcome it and hope that it stays. ...

Public Accounts Committee: 2015 Annual Report of the Comptroller and Auditor General and Appropriations Account
Chapter 13 - Revenue's Review of Medical Consultants' Tax Affairs
Chapter 14 - Research and Development Tax Credit
Chapter 16 - Deferral of Tobacco Stamp Liability (1 Jun 2017)

Bobby Aylward: Will Mr. Cody provide some of the details of the profile of companies that made research and development tax credit claims in 2015? What types of company are involved?

Public Accounts Committee: 2015 Annual Report of the Comptroller and Auditor General and Appropriations Account
Chapter 13 - Revenue's Review of Medical Consultants' Tax Affairs
Chapter 14 - Research and Development Tax Credit
Chapter 16 - Deferral of Tobacco Stamp Liability (1 Jun 2017)

Bobby Aylward: Are they food companies, pharmaceutical companies or something else?

Public Accounts Committee: 2015 Annual Report of the Comptroller and Auditor General and Appropriations Account
Chapter 13 - Revenue's Review of Medical Consultants' Tax Affairs
Chapter 14 - Research and Development Tax Credit
Chapter 16 - Deferral of Tobacco Stamp Liability (1 Jun 2017)

Bobby Aylward: Mr. Cody can forward it with the information on Deputy Cassells' question.

Public Accounts Committee: 2015 Annual Report of the Comptroller and Auditor General and Appropriations Account
Chapter 13 - Revenue's Review of Medical Consultants' Tax Affairs
Chapter 14 - Research and Development Tax Credit
Chapter 16 - Deferral of Tobacco Stamp Liability (1 Jun 2017)

Bobby Aylward: And by size.

Public Accounts Committee: 2015 Annual Report of the Comptroller and Auditor General and Appropriations Account
Chapter 13 - Revenue's Review of Medical Consultants' Tax Affairs
Chapter 14 - Research and Development Tax Credit
Chapter 16 - Deferral of Tobacco Stamp Liability (1 Jun 2017)

Bobby Aylward: Deputy Cassells referred to small companies. We all know about large companies, especially American and German multinationals. Would they be getting a bite of this credit? Would the likes of large Irish companies like Glanbia or Kerry Group get it or would it only be for small companies of ten or 20 workers undertaking small research? I suppose that the bulk of the credit is going to the...

Public Accounts Committee: 2015 Annual Report of the Comptroller and Auditor General and Appropriations Account
Chapter 13 - Revenue's Review of Medical Consultants' Tax Affairs
Chapter 14 - Research and Development Tax Credit
Chapter 16 - Deferral of Tobacco Stamp Liability (1 Jun 2017)

Bobby Aylward: If a small company in a village in County Kilkenny was starting something innovative, it would be fully entitled to claim.

Public Accounts Committee: 2015 Annual Report of the Comptroller and Auditor General and Appropriations Account
Chapter 13 - Revenue's Review of Medical Consultants' Tax Affairs
Chapter 14 - Research and Development Tax Credit
Chapter 16 - Deferral of Tobacco Stamp Liability (1 Jun 2017)

Bobby Aylward: Does the research and development credit attract international companies when we compete against Britain, Germany, America or Canada? Is it another incentive for them to come?